Coherus Oncology, Inc. Operating Leases, Future Minimum Payments, Due in Two Years
Coherus Oncology, Inc. (CHRS) had Operating Leases, Future Minimum Payments, Due in Two Years of $2.69 million as of 2018-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2020-02-27
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $2.69M; Operating Leases, Future Minimum Payments, Due in Two Years as first filed $27.07M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $2.59M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $2.60M.
- 2016-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $1.89M.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years | Operating Leases, Future Minimum Payments, Due in Two Years as first filed |
|---|---|---|
| 2018-12-31 | $2.69M 10-K · filed 2020-02-27 | $27.07M 10-K · filed 2019-02-28 |
| 2017-12-31 | $2.59M 10-K · filed 2018-03-08 | |
| 2016-12-31 | $2.60M 10-K · filed 2017-03-14 | |
| 2016-09-30 | $1.89M 10-Q · filed 2016-11-09 | |
| 2015-12-31 | $1.28M 10-K · filed 2016-02-29 | |
| 2015-09-30 | $1.69M 10-Q · filed 2015-11-10 | |
| 2014-12-31 | $1.12M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |